and the protozoan responsible for trichomoniasis.
Trichomoniasis continues to be a major sexually transmitted disease in the world. With the emergence of resistance to drugs in strains of Trichomonas vaginalis,' the development of a vaccine represents an important and necessary step towards eradication or at least control of this disease.
The use of Lactobacillus acidophilus as a vaccine for T vaginalis infections has received attention. 2' Reports indicate that the successful immunisation of women is due to the generation of antibody that recognises determinants common to antigens of both lactobacillus and the pathogenic human trichomonads.56 Data conflict about the extent and nature of such antigenic relatedness in the lactobacillus and T vaginalis organisms.>' Using several modern techniques and biofunctional assays, I obtained data indicating that no cross reactivity exists between the lactobacillus used in the Solco Trichovac vaccine2
and the protozoan responsible for trichomoniasis.
Materials and methods T VAGINALIS STRAINS, LACTOBACILLI, AND

ANTISERA
All the T and 7 x 105 lactobacilli were used to coat the polyvinyl microtitre wells (fig 1 (a) ). The antiserum L acidophilus from the individual rabbits was then pooled for use in the experiments outlined. The procedure for using T vaginalis organisms as the test antigen has been described previously."
Indirect immunofluorescence with live T vaginalis parasites was performed using techniques reported previously.9'`'5 In this case, the rabbit antisera to lactobacillus were heat inactivated at 56°C for 15 minutes immediately before being added to trichomonads. Rabbit antiserum to T vaginalis strain NYH 28689 was used as a positive control to show fluorescence reactions.
Immunoblot'3 was performed with total trichloroacetic acid precipitated proteins of T vaginalis strains8 and the bovine trichomonad, Tritrichomonas foetus.'6 Radioimmunoprecipitation assays using detergent extracts of both surface radiolabelled9 and intrinsically radiolabelled8 parasites were also performed using methods detailed elsewhere."9 3`5 Antiserum`and monoclonal antibodies'"'5 reactive with T vaginalis protein antigens were used as positive controls for these assays.
CYTADHERENCE AND CYTOTOXICITY ASSAYS
Monolayers of HeLa cells incubated with trichomonads labelled with tritiated (3H)thymidine'012 were used to study the effect of antiserum to lactobacillus on trichomonal cytadherence. Parasites were pretreated with up to 50% heat inactivated pooled antiserum to lactobacillus for different times up to one hour. The suspension of T vaginalis containing the antiserum to lactobacillus was then added to cell monolayers'2 and incubated in a 5% carbon dioxide humidified atmosphere for 30 minutes at 37°C. Coverslips were then extensively washed in PBS before being immersed in scintillation vials containing the cocktail and having their radioactivity measured.
A quantitative colorimetric assay using HeLa cells in monolayer cultures was used to assess the extent of host cell killing.'0 For these experiments, different concentrations of high titred antiserum to lactobacilli were included with the mixture of parasite and host cells throughout the 18 hour incubation.'R esults ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
It was first necessary to show the presence of antibody (fig 1 (a) ). Antiserum to the trichomonal strain NYH 286, however, gave strong ELISA readings with all seven strains but failed to react with the lactobacilli coated wells (fig 1 (b) ).
Alderete INDIRECT IMMUNOFLUORESCENCE
It was then important to test for any immunofluorescence of T vaginalis with the pooled antiserum to lactobacillus. Figure 2 shows that, whereas rabbit antiserum to strain NYH 286 gave strong fluorescence of live organisms, antibody to the Solco Trichovac L acidophilus gave no fluorescence with parasites ofthree strains, which indicated no trichomonad surface recognition.
IMMUNOBLOT AND RADIOIMMUNOPRECIPITATION ASSAYS   Fig 3 (a) shows many trichomonad protein antigens immobilised on nitrocellulose with rabbit antiserum to T vaginalis strain NYH 286. The extent of any trichomonad protein recognition of duplicate immunoblots incubated with antiserum to Solco Trichovac lactobacillus (b) equalled the minor reactivity obtained with prebleed control serum (c). Finally, any cross reaction between antiserum to Solco Trichovac lactobacillus and radiolabelled T vaginalis antigens was tested by the radioimmunoprecipitation assay (fig 4) . Under no circumstances were trichomonad proteins labelled with either radioiodine ('25I) (surface) or radiosulphate (internal) (5S) precipitated when Staphylococcus aureus bearing protein A was added to extracts containing antiserum to lactobacillus. Furthermore, antisera from two people immunised with the Solco Trichovac vaccine7 also failed to show any formation of antigen and antibody immune complexes (data not shown). On the other hand, the use of rabbit antiserum strain NYH 28689 or monoclonal antibody C20A3, which is known to react with a high molecular weight immunogen,'1'5 readily resulted in the precipitation of appropriate protein(s). As expected, no reaction with parasite proteins was observed with prebleed control serum. 
